AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, and YouTube.

We are AbbVie. A global Fortune 500 biopharmaceutical company creating life-changing medicines and first-in-kind solutions that make a real difference in people’s lives.

Our 50,000+ employees across geographies, disciplines, and therapeutic areas put impact at the core of every decision. With over $50B invested in R&D since our founding in 2013, we’re always focused on helping people and communities thrive for generations to come.

1 North Waukegan Road
North Chicago, IL 60064

Tel: 1-800-255-5162

Visit website

Email Us

Stock Symbol: ABBV
Stock Exchange: NYSE

NEWS

Policy

House Oversight Committee Takes on Pharma Industry

It didn’t take long for the new leadership structure in the U.S. House of Representatives to take on the pharmaceutical industry. On Monday, the House Committee on Oversight and Reform launched an investigation into prescription drug pricing practices.

January 15, 2019

2 min read

Alex Keown

Employer Resources

Top 10 Cities in the U.S. for the Job Market

New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.

January 14, 2019

3 min read

Mark Terry

Policy

M&A May Be the Legacy of the Trump Tax Cuts for Pharma

Federal corporate tax cuts that were framed as a way to give a boost to employment across the United States have been more beneficial to companies and shareholders than the average worker or consumer, a new report issued by the advocacy group Americans for Tax Fairness shows.

January 8, 2019

3 min read

Alex Keown

Business

AbbVie Forges $105 Million+ CD39 Inhibitor Alliance With Tizona

Privately-held Tizona Therapeutics snagged $105 million in upfront cash as its cancer antibody TTX-030 is the centerpiece of a collaborative effort with Illinois-based AbbVie.

January 4, 2019

2 min read

Alex Keown

Job Trends

Top 12 Life Sciences Companies Hiring Now in 2019

It’s a new year! Is one of your New Year’s resolutions to find a new job? Jump start your job search now and check out top companies who are looking for quality candidates in 2019!

January 4, 2019

1 min read

Editorial Staff

Business

AbbVie Strikes Deal With Lupin for Blood Cancer Program

AbbVie closed out 2018 by striking a nearly $1 billion licensing deal for India-based Lupin Limited’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.

January 2, 2019

2 min read

Alex Keown

Business

AbbVie Strategically Restructures Executive Leadership Team

The new structure creates four top managers who will report directly to the company CEO. All other executives will report to those managers.

December 18, 2018

2 min read

Alex Keown

Drug Development

Eli Lilly’s Taltz Stands up to Humira in Psoriatic Arthritis Patients

At 24 weeks, the study met its primary endpoint. Lilly’s Taltz demonstrated superiority against AbbVie’s Humira, the best-selling drug in the world, in improving the signs and symptoms of active PsA.

December 17, 2018

2 min read

Alex Keown

Pharm Country

Readers’ Picks: Top 10 Stories of 2018

As we look back over the year, we noticed some stories just grabbed readers more than others. Here’s a look at the top 10 stories of the year, including job cuts, best-selling drugs, up-and-coming companies,scandals, clinical trials, and more.

December 13, 2018

5 min read

Mark Terry

JOBS